about
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...
Read More
2.44
0.04
(1.67%)
4.7M
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for ImmunityBio Inc is on 12 Aug 2025 for the purpose of ImmunityBio Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
ImmunityBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..